Current Treatment Options in Oncology

Papers
(The TQCC of Current Treatment Options in Oncology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer96
Role of Metastasis-Directed Therapy in Genitourinary Cancers71
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies68
An Update on Temporal Bone Paragangliomas66
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes65
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer53
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia51
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect50
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead48
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma48
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)43
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T41
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?39
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?38
Approach to Localized Squamous Cell Cancer of the Esophagus37
Small Cell Lung Cancer—An Update on Chemotherapy Resistance35
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer34
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers34
The Role of Nursing in the Delivery of Cardio-Oncology31
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma29
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements28
Management of Fatigue in Patients with Advanced Cancer28
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management28
Regorafenib for the Treatment of Sarcoma27
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer26
Advances in Targeted Therapy for Metastatic Prostate Cancer25
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?25
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations24
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer24
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities24
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?23
Gastric Cancer with Sarcopenia: an Area Worth Focusing On23
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?23
Recognition and Management of the Long-term Effects of Cranial Radiation23
Optimal Strategies for Colorectal Cancer Screening22
Novel Approaches for the Treatment of Patients with Richter’s Syndrome22
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs22
New Treatment Options for Newly-Diagnosed and Relapsed Chronic Lymphocytic Leukemia22
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia21
How to Sequence Therapies in Mycosis Fungoides21
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas21
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities20
Treatment Options for Brain Metastases20
Response Evaluation of Neoadjuvant Therapies in Sarcoma20
Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives20
Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy20
Correction to: The Microbiome: the Link to Colorectal Cancer and Research Opportunities20
R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond20
Dyadic Interventions for LGBTQ+ Individuals Facing Cancer: A Narrative Review19
Research Progress on Ferroptosis in Multiple Myeloma19
How to Sequence Therapies in Diffuse Large B-Cell Lymphoma Post-CAR-T Cell Failure19
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis19
Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer19
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment18
Novel Estrogen Receptor-Targeted Agents for Breast Cancer17
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms17
Treating Chronic Pain with Buprenorphine—The Practical Guide17
New Therapeutic Targets in RAS Wild-type Pancreatic Cancer17
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer17
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors17
Therapeutic Challenges in the Management of Serous Endometrial Intraepithelial Carcinoma (SEIC)17
New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer16
How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia16
Contemporary Review of Adenocarcinoma of the Cervix16
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives16
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract16
Updates in Management of Malignant Pleural Mesothelioma16
The Dilemma of Treating Delirium: the Conundrum of Drug Management16
Progress in the Treatment of Small Intestine Cancer16
Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers15
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations15
Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma15
Navigating PARP Inhibitor Resistance in Ovarian Cancer: Bridging Mechanistic Insights To Clinical Translation15
Updates in Breast Cancer Screening and Diagnosis15
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management15
The Role of Induction Therapy for Sinonasal Cancers15
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?15
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease15
Non-chemotherapy Options for Newly Diagnosed Mantle Cell Lymphoma15
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus14
Advances in PSMA-Targeted Radionuclide Therapeutics14
“When Less is More”: Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer14
Correction to: Cardiotoxicity of Systemic Melanoma Treatments14
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer14
A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective13
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy13
The Role of SIRT1 in Leukemia13
Re-thinking the Role of Thoracic Radiotherapy in the First-Line Treatment for Extensive-Stage Small Cell Lung Cancer13
Complex Persistent Opioid Dependence—an Opioid-induced Chronic Pain Syndrome12
Myxoid Liposarcomas: Systemic Treatment Options12
Correction to: Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies12
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review12
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management12
The Use of Targeted Agents in the Treatment of Gynecologic Cancers12
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?12
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?12
Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors12
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance12
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions11
Management of Functional Pancreatic Neuroendocrine Neoplasms11
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?11
Cardio-Oncology Care Delivered in the Non-academic Environment11
Systemic Management of Advanced Adrenocortical Carcinoma11
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming11
HER2-Positive Metastatic Colorectal Cancer11
Advancements in Melanoma Therapies: From Surgery to Immunotherapy11
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer11
Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice11
Therapeutic Management of Malignant Wounds: An Update11
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation11
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches11
Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes11
0.19457602500916